Roche
10
118M
6
0.08
4
0.40
3
- Areas of investment
Summary
In 1896 was created Roche, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Basel. The company was established in Europe in Switzerland.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Roche, startups are often financed by OrbiMed, Novo Holdings, Life Sciences Partners. The meaningful sponsors for the fund in investment in the same round are GBS Ventures, No 8 Ventures, Stripes. In the next rounds fund is usually obtained by No 8 Ventures, GBS Ventures, New Zealand Venture Investment Fund.
The important activity for fund was in 2016. Comparing to the other companies, this Roche performs on 4 percentage points more the average number of lead investments. The higher amount of exits for fund were in 2018. Considering the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The average startup value when the investment from Roche is more than 1 billion dollars. The common things for fund are deals in the range of 50 - 100 millions dollars.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Flatiron Health, C4 Therapeutics, Proacta. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Software, Medical.
Besides them, we counted 34 critical employees of this fund in our database.
Investments analytics
Analytics
- Total investments
- 10
- Lead investments
- 4
- Exits
- 3
- Rounds per year
- 0.08
- Follow on index
- 0.40
- Investments by industry
- Health Care (9)
- Biotechnology (8)
- Health Diagnostics (6)
- Personal Health (4)
- Medical Device (3) Show 5 more
- Investments by region
-
- United States (8)
- Germany (1)
- Israel (1)
- Peak activity year
- 2016
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 316M
- Group Appearance index
- 0.80
- Avg. company exit year
- 6
- Avg. multiplicator
- 5.85
- Strategy success index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Sentient Med | 01 Jul 2021 | Health Care, Health Diagnostics | Seed | Tel Aviv, Herzliya, Israel |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.